- Home
- CVM vs PCH Comparison
CVM vs PCH Comparison
Compare CVM & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVM | PCH |
|---|---|---|
| Founded | 1983 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.1M | 3.0B |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVM | PCH |
|---|---|---|
| Price | $6.33 | $40.26 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $45.67 |
| AVG Volume (30 Days) | 58.9K | ★ 500.6K |
| Earning Date | 01-12-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 4.43% |
| EPS Growth | N/A | ★ 312.61 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $1,115,571,000.00 |
| Revenue This Year | N/A | $3.38 |
| Revenue Next Year | N/A | $1.91 |
| P/E Ratio | ★ N/A | $49.61 |
| Revenue Growth | N/A | ★ 5.40 |
| 52 Week Low | $1.98 | $36.82 |
| 52 Week High | $32.70 | $48.12 |
Technical Indicators
Market Signals| Indicator | CVM | PCH |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 53.29 |
| Support Level | $6.20 | $39.02 |
| Resistance Level | $6.69 | $41.90 |
| Average True Range (ATR) | 0.54 | 0.93 |
| MACD | 0.05 | 0.23 |
| Stochastic Oscillator | 35.71 | 55.75 |
Price Performance
Historical ComparisonAbout CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About PCH PotlatchDeltic Corporation
PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.